Masahiko Fukatsu
Overview
Explore the profile of Masahiko Fukatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sato Y, Koyama D, Yamada S, Kamei N, Fukuchi K, Suzuki K, et al.
Fukushima J Med Sci
. 2025 Feb;
PMID: 39909446
H3K4 methylation, primarily mediated by MLL family proteins, plays a pivotal role in the epigenetic regulation of gene transcription. Among the MLL family, KMT2A is known for its critical role...
2.
Kawano N, Ikezoe T, Seki Y, Yamakawa K, Okamoto K, Fukatsu M, et al.
Int J Hematol
. 2024 Dec;
PMID: 39674834
Disseminated intravascular coagulation (DIC) associated with hematologic malignancies, particularly acute promyelocytic leukemia (APL), is characterized by marked fibrinolytic activation, which leads to severe bleeding complications. Therefore, appropriate diagnosis and management...
3.
Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, et al.
J Clin Exp Hematop
. 2024 Jul;
64(3):191-202.
PMID: 39085129
Immune checkpoint inhibitors (ICI) are promising therapeutic agents for relapsed or refractory classical Hodgkin's lymphoma (RRcHL). This retrospective study evaluated patients with RRcHL registered in the clinical research program Tohoku-Hematology-Forum-26,...
4.
Suzuki K, Koyama D, Oka Y, Sato Y, Sekine R, Fukatsu M, et al.
Int J Hematol
. 2024 Jun;
120(3):382-388.
PMID: 38861243
The classification of clonal plasmacytoid dendritic cell (pDC) proliferation associated with myeloid neoplasms remains a topic of ongoing debate. Although the fifth edition of the World Health Organization classification classifies...
5.
Fukatsu M, Ikezoe T
Int J Hematol
. 2024 Jan;
119(5):516-525.
PMID: 38270784
Patients with hematologic malignancies are often complicated not only by severe bleeding due to thrombocytopenia and disseminated intravascular coagulation but also by thromboembolic events, just like in patients with solid...
6.
Kawano N, Fukatsu M, Yamakawa K, Seki Y, Wada H, Okamoto K, et al.
Int J Hematol
. 2024 Jan;
119(4):416-425.
PMID: 38270783
Background: Recombinant human soluble thrombomodulin (rhTM) is commonly used in Japan to treat disseminated intravascular coagulation (DIC), but its efficacy compared with other anticoagulants is unclear. We conducted a systematic...
7.
Okoshi C, Takahashi T, Fukatsu M, Suganuma R, Ikezoe T, Fujimori K
Fukushima J Med Sci
. 2023 Oct;
69(3):197-204.
PMID: 37853641
Von Willebrand disease (VWD) is a bleeding disorder caused by a congenital quantitative reduction, deficiency, or qualitative abnormality of the von Willebrand factor (VWF). Here, we report a case of...
8.
Hayashi K, Koyama D, Sato Y, Fukatsu M, Ikezoe T
Br J Haematol
. 2023 Sep;
203(5):e110-e113.
PMID: 37697431
No abstract available.
9.
Uchida Y, Koyama D, Manabe K, Suzuki K, Asano N, Endo M, et al.
Intern Med
. 2023 Jul;
63(5):717-720.
PMID: 37407456
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm driven by the BCR::ABL1 tyrosine kinase. Tyrosine kinase inhibitors (TKIs) have been established as standard therapies for CML. However, some CML patients...
10.
Fukatsu M, Hamazaki Y, Sato Y, Koyama D, Ikezoe T
Int J Hematol
. 2023 May;
118(4):472-476.
PMID: 37133636
Cold agglutinin disease (CAD) is a rare cold autoimmune haemolytic anaemia (cAIHA) caused by IgM antibodies recognizing I antigens on erythrocytes. cAIHA is now mainly classified into two types: primary...